AnalystsInsight

Carey MacRury (Canaccord Genuity): Analyst Track Record and Price‑Target Accuracy

How often Carey MacRury’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 122 ratings, compared with the average Wall Street analyst.

3 min readHow we research

Key takeaways

  • Carey MacRury ranks #59 of 1,000 analysts in Exent’s scoring (5.0★).
  • 50.0% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 84 days; 37.6% of calls were up 12 months later.
  • Most‑covered stocks: TSX-TFPM, TSX-BTO, TSX-AGI, TSX-ELE.

Carey MacRury’s track record at a glance

Carey MacRury of Canaccord Genuity ranks #59 of the 1,000 analysts Exent scores, with a 5.0★ rating and a focus on materials. Over a 7‑year lookback, 50.0% of Carey’s price targets were reached, 2.4 points below the 52.4% average across all analysts.

MetricCarey MacRuryAll analysts
Price‑target hit rate50.0%52.4%
Median days to hit target84 days91 days
Calls up after 12 months37.6%64.0%
Median 12‑month return of calls−4.6%+13.4%
Hit rate, last 2 years75.7%—
Average worst drop after a call−19.4%—
Ratings in the sample122—
Stocks covered36—

How fast price targets were reached

Time to reach the targetCarey MacRury
Under 30 days10.2%
30–90 days49.2%
90–180 days25.4%
Over 180 days15.3%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Carey MacRury covers most

StockRatings in the sample
TSX-TFPM23
TSX-BTO22
TSX-AGI21
TSX-ELE21
TSX-MAU20
TSX-FNV20
TSX-ARIS19
TSX-ELD18

In the past year Carey’s ratings were 87% Buy, 13% Hold and 0% Sell.

Recent ratings (shown with a 30-day delay)

DateStockActionRatingPrice target
Aug 26, 2026TSXV-SUMInitiated Coverage: BuyBuy$2.50
Jul 6, 2026TSX-TFPMReiterated: BuyBuy$55.00
Jun 11, 2026TSX-TFPMUpgraded: BuyBuy$52.00
Jun 11, 2026TSX-TFPMUpgradedHold → Buy$52.00
Jun 1, 2026TSX-AAUCUpgradedHold → Buy$44.00
Jun 1, 2026TSX-AAUCUpgraded: BuyBuy$44.00
May 26, 2026TSX-MAUMaintainedBuy$20.00
May 26, 2026TSX-MAUMaintained: BuyBuy$20.00
May 26, 2026TSX-MAUReiterated: BuyBuy$20.00
May 15, 2026TSX-MAUMaintainedBuy$18.00
May 15, 2026TSX-MAUMaintained: BuyBuy$18.00
May 15, 2026TSX-MAUReiterated: BuyBuy$18.00
  • Aug 26, 2026
    Stock
    TSXV-SUM
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $2.50
  • Jul 6, 2026
    Stock
    TSX-TFPM
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $55.00
  • Jun 11, 2026
    Stock
    TSX-TFPM
    Action
    Upgraded: Buy
    Rating
    Buy
    Price target
    $52.00
  • Jun 11, 2026
    Stock
    TSX-TFPM
    Action
    Upgraded
    Rating
    Hold → Buy
    Price target
    $52.00
  • Jun 1, 2026
    Stock
    TSX-AAUC
    Action
    Upgraded
    Rating
    Hold → Buy
    Price target
    $44.00
  • Jun 1, 2026
    Stock
    TSX-AAUC
    Action
    Upgraded: Buy
    Rating
    Buy
    Price target
    $44.00
  • May 26, 2026
    Stock
    TSX-MAU
    Action
    Maintained
    Rating
    Buy
    Price target
    $20.00
  • May 26, 2026
    Stock
    TSX-MAU
    Action
    Maintained: Buy
    Rating
    Buy
    Price target
    $20.00
  • May 26, 2026
    Stock
    TSX-MAU
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $20.00
  • May 15, 2026
    Stock
    TSX-MAU
    Action
    Maintained
    Rating
    Buy
    Price target
    $18.00
  • May 15, 2026
    Stock
    TSX-MAU
    Action
    Maintained: Buy
    Rating
    Buy
    Price target
    $18.00
  • May 15, 2026
    Stock
    TSX-MAU
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $18.00

Live ratings from Carey MacRury and the other top‑ranked analysts, and the stocks where they agree, are in Exent Stocks Radar.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 16, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Stocks Radar shows Carey MacRury’s live ratings and those of the other top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Carey MacRury ranks #59 of 1,000 with a 5.0★ rating. 50.0% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 37.6% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Carey MacRury’s success rate is 66.3% by the ranking source and 50.0% by Exent’s price-target hit-rate backtest, with a median of 84 days to reach a target.

Carey MacRury (Canaccord Genuity) covers 36 stocks, mostly in materials. The most frequently rated are TSX-TFPM, TSX-BTO, TSX-AGI, TSX-ELE, TSX-MAU.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.